Vol. 17.Issue. 2. March - April 2018 | Annals of Hepatology

¿Aún no está registrado?

Información relevante

Consulte los artículos y contenidos publicados en éste medio, además de los e-sumarios de las revistas científicas en el mismo momento de publicación

Máxima actualización

Esté informado en todo momento gracias a las alertas y novedades

Promociones exclusivas

Acceda a promociones exclusivas en suscripciones, lanzamientos y cursos acreditados

Crear Mi cuenta

* = Required fields

Enter your email address

User name *

Annals of Hepatology

Buscar en

Annals of Hepatology

Toda la web

Inicio Annals of Hepatology

ISSN: 1665-2681

Annals of Hepatology (AoH) is an international, open access journal published bi-monthly with funds from the Fundación Clínica Médica Sur. It is the official journal of the Mexican Association of Hepatology (AMH), the Latin American Association for the Study of the Liver (ALEH), the Canadian Association for the Study of the Liver (CASL) and the Czech Society of Hepatology (CSH). AoH publishes editorials, opinions, concise reviews, original articles, brief reports, letters to the editor, news from affiliated associations, clinical practice guidelines and summaries of congresses in the field of Hepatology.

Topics covered by AoH include alcoholic liver disease, autoimmune hepatitis, biliary diseases, drug-induced liver injury, genetic liver diseases, NAFLD/NASH and viral hepatitis (HAV, HBV, HCV, HDV, HEV). Our journal seeks to publish articles on basic clinical care and translational research focused on preventing rather than treating the complications of end-stage liver disease.

See more Open Access Option

Indexed in:

Scopus, Web of Science, Medline/PubMed, DOAJ and Conacyt

See more

Follow us:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

See more

Impact factor 2022

3.8

Citescore

CiteScore measures average citations received per document published.

See more

Citescore 2022

6.3

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more

SJR 2022

0.859

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more

SNIP 2022

0.989

View more metrics

Journal Information

Previous Issue | Next Issue

Issue

Vol. 17. Issue 2.

Pages 180-338 (March - April 2018)

Editorial

Natural Extracts as Modifiers of Intracellular Lipid Handling

Rosellina Margherita Mancina, Piero Pingitore

Ann Hepatol. 2018;17:180-1

Open access

Opinion

Nonalcoholic Fatty Liver Disease Progresses into Severe NASH when Physiological Mechanisms of Tissue Homeostasis Collapse

Silvia Sookoian, Carlos J. Pirola

Ann Hepatol. 2018;17:182-6

Open access

Viewpoint

Recent Advances in Hepatotoxicity of Non Steroidal Anti-inflammatory Drugs

Lucy Meunier, Dominique Larrey

Ann Hepatol. 2018;17:187-91

Open access

Concise review

Fontan-Associated Liver Disease: A Review

Luis Téllez, Enrique Rodríguez-Santiago, Agustín Albillos

Ann Hepatol. 2018;17:192-204

Open access

Viscoelastic Testing in Liver Disease

Jessica P.E. Davis, Patrick G. Northup, Stephen H. Caldwell, Nicolas M. Intagliata

Ann Hepatol. 2018;17:205-13

Open access

Original article

TCR Vβ Usage of Peripheral Blood and Liver Infiltrating Lymphocytes in Patients with Chronic Hepatitis B

Jianwei Zhou, Cui Kong, Bo Ban, Haixin Dong, Chengqiang Jin

Ann Hepatol. 2018;17:214-22

Open access

Early Successes in an Open Access, Provincially Funded Hepatitis C Treatment Program in Prince Edward Island

Jordan W. Francheville, Robin Rankin, Jeremy Beck, Connie Hoare, Stefanie Materniak, Greg German, Lisa Barrett, Natalie Bunimov-Wall, Daniel Smyth

Ann Hepatol. 2018;17:223-31

Open access

Long-Term Follow-up and Quantitative Hepatitis B Surface Antigen Monitoring in North American Chronic HBV Carriers

Conar R. O’Neil, Stephen E. Congly, M. Sarah Rose, Samuel S. Lee, Meredith A. Borman, Carmen L. Charlton, Carla Osiowy, Mark G. Swain, ... Carla S. Coffin

Ann Hepatol. 2018;17:232-41

Open access

Natural Extracts Abolished Lipid Accumulation in Cells Harbouring non-favourable PNPLA3 genotype

Ángela Rojas, Paloma Gallego, Antonio Gil-Gómez, Rocío Muñoz-Hernández, Lourdes Rojas, Rosario Maldonado, Rocío Gallego-Durán, Marta García-Valdecasas, ... Manuel Romero-Gómez

Ann Hepatol. 2018;17:242-9

Open access

More Evidence for the Genetic Susceptibility of Mexican Population to Nonalcoholic Fatty Liver Disease through PNPLA3

Paulina Chinchilla-López, Oscar Ramírez-Pérez, Vania Cruz-Ramón, Samuel Canizales-Quinteros, Aarón Domínguez-López, Guadalupe Ponciano-Rodríguez, Fausto Sánchez-Muñoz, Nahum Méndez-Sánchez

Ann Hepatol. 2018;17:250-5

Open access

Results of Liver Transplantation for Hepatocellular Carcinoma in a Multicenter Latin American Cohort Study

Federico Pinero, Paulo Costa, Yuri L. Boteon, Sergio Hoyos Duque, Sebastian Marciano, Margarita Anders, Adriana Varón, Alina Zerega, ... On behalf of the Latin American Liver Research, Education and Awareness Network (LALREAN).

Ann Hepatol. 2018;17:256-67

Open access

Safety and Efficacy of Laparoscopic Radiofrequency Ablation for Hepatic Hemangiomas: A Multicenter Retrospective Study

Shun-Qian Wen, Ming Wan, Kai-Ming Len, Qiu-Hui Hu, Xue-Yi Xie, Qing Wu, Guan-Qun Liao

Ann Hepatol. 2018;17:268-73

Open access

Racial, Ethnic, and Age Disparities in Incidence and Survival of Intrahepatic Cholangiocarcinoma in the United States; 1995-2014

Samuel O. Antwi, Omar Y. Mousa, Tushar Patel

Ann Hepatol. 2018;17:274-85

Open access

Clinical Significance of Serum Adiponectin and Resistin Levels in Liver Cirrhosis

Telma Erotides da Silva, Mariana Costa-Silva, Carina G. Correa, Giovana Denardin, Maria L. Ayres Alencar, Mara S. Pacheco Honório Coelho, Letícia Muraro-Wildner, Maria Luiza-Bazzo, ... Leonardo de Lucca Schiavon

Ann Hepatol. 2018;17:286-99

Open access

Treatment of Type-1 Hepatorenal Syndrome with Pentoxifylline: A Randomized Placebo Controlled Clinical Trial

Jonathan G. Stine, Jennifer Wang, Scott L. Cornella, Brian W. Behm, Zachary Henry, Neeral L. Shah, Stephen H. Caldwell, Patrick G. Northup

Ann Hepatol. 2018;17:300-6

Open access

Antifibrotic Mechanism of Pinocembrin: Impact on Oxidative Stress, Inflammation and TGF-β /Smad Inhibition in Rats

Marwa M. Said, Samar S. Azab, Noha M. Saeed, Ebtehal El-Demerdash

Ann Hepatol. 2018;17:307-17

Open access

Bacterial Translocation Is Linked to Increased Intestinal IFN-γ, IL-4, IL-17, and mucin-2 in Cholestatic Rats

Natali Vega-Magaña, Vidal Delgado-Rizo, Leonel García-Benavides, Susana del Toro-Arreola, Jorge Segura-Ortega, Adelaida Sara M. Zepeda Morales, José Sergio Zepeda-Nuño, Marta Escarra-Senmarti, ... Miriam R. Bueno-Topete

Ann Hepatol. 2018;17:318-29

Open access

Image in hepatology

Impact of Cholangioscopy: Diagnosing Sclerosing Cholangitis-Associated Biliary Calculi not Detected Using MRI and Endoscopic Ultrasound

Waleed Fateen, Nick Taylor, Martin W. James

Ann Hepatol. 2018;17:330-1

Open access

Case report

Incomplete Kawasaki Disease in an Infant with Cholangitis Post Kasai Surgery for Biliary Atresia

Naman S. Shetty, Ira Shah

Ann Hepatol. 2018;17:332-4

Open access

Hepatitis E Virus Genotype 1 Cases Imported to Portugal from India, 2016

João R. Mesquita, Madalena Almeida-Santos, Maria Fernandes, Fernando Maltez, Sara Lino, Liliana Alves, Joana Abreu-Silva, Ricardo M.S. Oliveira, ... Maria S.J. Nascimento

Ann Hepatol. 2018;17:335-8

Open access